Genentech Licenses BioInvent's Cardiovascular Drug Candidate

Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics by ruth on January 15, 2007

Genentech, Inc. is paying an upfront payment of $15 million to co-develop and commercialize BioInvent´s proprietary antibody candidate, BI-204, for the potential treatment of multiple cardiovascular conditions. In addition, BioInvent could receive further milestone payments of up to $175 million as well as royalties on sales in North America.

BI-204 is developed to prevent atherosclerosis and myocardial infarction by blocking a major mediator of vascular inflammation that is believed to lead to the formation of unstable plaque in the vessel wall.

Source: BioInvent

Related Entries:

Annual Flu Shot May Protect Cardiovascular Disease Patients,... - 20 September 2006
Epoxide Hydrolase Inhibitors from Insects: Potential Drug Ca... - 27 November 2006
Adipose-Derived Stem Cell Therapy for Cardiovascular Disease - 09 February 2007
Muscadine Grapeseed Supplement on Clinical Trial for CArdiov... - 26 October 2007

« Pharmaceuticals from Gene... | Main | Blood Test for NT-proBNP ... »

Permalink: Genentech Licenses BioInvent's Cardiovascular Drug Candidate

Tags: cardiovascular+disease athersclerosis myocardial+infarct Genentech BioInvent biotech drug+candidate

Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/49322

Addthis

Ask

Blinklist

del.icio.us

Digg

Fark

Facebook

Google

Lycos

Ma.gnolia

Mr Wong

Netscape

Netvousz

Newsvine

StumbleUpon

Slashdot

Tailrank

Technorati

Wink

Yahoo

Vote for Genentech Licenses BioInvent's Cardiovascular Drug Candidate:

Currently 9.25/10
1
2
3
4
5
6
7
8
9
10

Rating: 9.25 out of 4 vote(s) cast.

Add your response to Genentech Licenses BioInvent's Cardiovascular Drug Candidate:

Name: *

Email: (will never be shown)*

URL:

(* marked fields are required)

Notify me if more comments appear?

Subscribe to The Biotech Weblog newsletter? (Newsletters are sent out weekly).

Remember me

Security Code: *
(Please help us to sort out spam.)

Please enter your comment here: (Sorry, no HTML is allowed - URLs will be made clickable automatically if you add http:// to your URL.)

We welcome your comments, however all comments are moderated. Offensive or off-topic comments will be deleted and not displayed.

Share It

Use the search to look for other interesting posts

Contributors (Last 90 days)

Gloria Gamat (4)
Ruth Schaffer (15)
Creative Weblogging (3)

This site has 1332 entries and is powered by Creative Weblogging since July 2005.

Our Editors recommend

Disclaimer

Some of the contents of this site are protected Creative Weblogging Inc. 2004-2010.

Check out our Sponsored Blogs!

Business Computer Blog (UK)

Are you interested in writing a blog in our network?

See which positions are currently open.

Testimonials

'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

'I subscribe to your blog and have been enjoying your posts and perspective.'

Other blogs in the same channel in the Creative Weblogging Network: Health & Life Sciences

RSS	See all blog subscribe options
Google	What is RSS?
Yahoo!
Addthis
Bloglines
Newsletter
Twitter	Follow us on Twitter!